MariappanP., SmithG., BariolS.V., MoussaS.A., TolleyD.A.Stone and pelvic urine colture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: a prospective clinical study.J Urol2005; 173: 1610–4.
AkagashiK., TandaH., KatoS.. Characteristics of patients with staghorn calculi in our experience.Int J Urol2004; 11: 276–81.
6.
AparnaM.S., YadavS.Biofilms: microbes and disease.Braz J Infect dis2008; 12: 526–30.
7.
GrenaboL., HedelinH., PettersonS.Urinary infection stones caused by Ureaplasma urealyticum: a review.Scand J Infect Dis1988; 53(suppl): S46–9.
8.
JohansenT.E., CekM., NaberK.G.. Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies.Int J Antimicrob Agents2006; 28(Suppl 1): S91–107.
9.
KajanderE.O., CiftçiogluN.Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation.Proc Natl Acad Sci USA1998; 95: 8274–9.
10.
MariappanP., SmithG., MoussaS.A., TolleyD.A.One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study.BJU Int2006; 98: 1075–9.
11.
ZanettiG., PaparellaS., TrinchieriA., PreziosoD., RoccoF., NaberK.G.Infections and Urolithiasis: current clinical evidence in prophylaxis and antibiotic therapy.Archivio Italiano di Urologia e Andrologia2008; 80: 5–12.
12.
MargelD., EhrlichY., BrownN., LaskD., LivneP.M., LifshitzD.A.Clinical implication of routine stone culture in percutaneous nephrolithotomy: a prospective study.Urology2006; 67: 26–9.
